Kawanishi H, Moriishi M, Katsutani S, Sakikubo E, Tsuchiya S
Akane-Foundation, Tsuchiya General Hospital, Hiroshima, Japan.
Adv Perit Dial. 1999;15:127-31.
When long-term peritoneal dialysis (PD) is performed without change in the dialysis prescription, uremic symptoms appear owing to insufficient dialysis dose. In such cases, an increase in dialysate volume is required, but this increase is difficult to obtain in all patients owing to limitations in abdominal volume, lifestyle, or body weight. A combination of PD and hemodialysis (HD) is the simplest method of overcoming these limitations. Combination therapy--HD once per week for 4 hours and PD 6 days per week--was performed in our patients. The total weekly dialysis dose (urea) was calculated as follows: to convert the dialysis dose by HD to that of continuous treatment, the equivalent renal urea clearance (EKR) was calculated and added to the dialysis dose by PD. Combination therapy was performed in 12 patients. The reasons for the combination therapy included ultrafiltration (UF) loss in 2 patients, uremic symptoms in 3 patients, poor fluid management in 5 patients, umbilical hernia in 1 patient, and hydrothorax in 1 patient. Total Kt/V per week was increased from 1.61 +/- 0.19 to 2.05 +/- 0.25 in these patients. In the 2 patients with UF loss, weight control became easier after the combination therapy was started, and this control was possible with hypotonic dialysate alone. In patients with uremic symptoms, the symptoms improved; furthermore, dermal pigmentation improved in these patients. In summary, the dialysis dose was increased and body fluids became controllable after inducing combination therapy, resulting in improvement uremic symptoms and increased quality of life.
在透析处方不变的情况下进行长期腹膜透析(PD)时,由于透析剂量不足会出现尿毒症症状。在这种情况下,需要增加透析液量,但由于腹腔容量、生活方式或体重的限制,并非所有患者都能实现这种增加。腹膜透析与血液透析(HD)联合是克服这些限制的最简单方法。我们的患者采用联合治疗——每周进行1次4小时的血液透析和每周6天的腹膜透析。每周的总透析剂量(尿素)计算如下:为了将血液透析的透析剂量换算为持续治疗的剂量,计算等效肾脏尿素清除率(EKR)并将其与腹膜透析的透析剂量相加。12例患者接受了联合治疗。联合治疗的原因包括2例超滤(UF)丢失、3例尿毒症症状、5例液体管理不佳、1例脐疝和1例胸腔积液。这些患者每周的总Kt/V从1.61±0.19增加到2.05±0.25。在2例超滤丢失的患者中,开始联合治疗后体重控制变得更容易,仅使用低渗透析液即可实现这种控制。在有尿毒症症状的患者中,症状得到改善;此外,这些患者的皮肤色素沉着也有所改善。总之,诱导联合治疗后透析剂量增加,体液变得可控,从而改善了尿毒症症状并提高了生活质量。